Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Bio Q2 Revenues Increase 10 Percent

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that its revenues for the second quarter improved 10 percent year over year, paced by a 60 percent growth in grant revenues.

For the three months ended June 30, the South Easton, Mass.-based firm recorded total revenues of $357,736, up from $324,908 a year ago. While revenues from PCT products and services retreated 8 percent to $196,522 from $224,384, grant revenues increased to $161,214 from $100,524.

Pressure Bio recorded a net loss in the second quarter of $1.1 million, or $.10 per share, compared to a net loss of $509,692, or $.11 per share, a year ago.

The company used 11.5 million shares to calculate its net loss per share figure for the recently completed quarter, compared to 10.2 million shares in Q2 2012.

R&D spending came in at $260,408, up 2 percent from $256,307 a year ago. SG&A costs was up 36 percent to $871,525 from $642,188.

The firm finished the quarter with $113,663 in cash and cash equivalents.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.